Skip to Content

CFZ 300 (Invokana 300 mg)

Generic Name: canagliflozin

Pill with imprint CFZ 300 is White, Capsule-shape and has been identified as Invokana 300 mg. It is supplied by Janssen Pharmaceuticals, Inc..

Invokana is used in the treatment of diabetes, type 2; cardiovascular risk reduction and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Invokana 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CFZ 300

Invokana 300 mg CFZ 300
Invokana 300 mg CFZ 300
Invokana 300 mg CFZ 300 Front
Invokana 300 mg CFZ 300 Back

Invokana

Generic Name:
canagliflozin
Imprint:
CFZ 300
Strength:
300 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
SGLT-2 inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Janssen Pharmaceuticals, Inc.
National Drug Code (NDC):
50458-0141

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide